Publication | Closed Access

The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure

Novel ImidazolineHeart FailureCardiogenic ShockCardiovascular DiseasePlasma NorepinephrineMedicineCardiovascular PharmacologyPharmacotherapyCongestive Heart FailureCardiovascular ToxicityPharmacologyCardiologyDiastolic Function